Economic Evaluation of Insulin Lispro versus Neutral (Regular) Insulin Therapy Using a Willingness-To-Pay Approach

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.3, 1998-03, pp. : 347-358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Economic Value of a New Insulin Preparation, Humalog Mix 25: Measured by a Willingness-To-Pay Approach

By Dranitsaris G.

PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. : 275-287

Adis International

Access to resources Recommend Favorite

Willingness to Pay for Inhaled Insulin: A Contingent Valuation Approach

By Sadri Hamid

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1215-1227

Adis International

Access to resources Recommend Favorite

Insulin lispro: a useful advance in insulin therapy

By Heller Simon

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1407-1416

Informa Healthcare

Access to resources Recommend Favorite

Insulin neutral protamine lispro/insulin lispro: Type I IgE-mediated hypersensitivity in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1437, 2013-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Insulin aspart/insulin lispro: Vitiligo: case report

Reactions Weekly, Vol. 1, Iss. 1016, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite